Skip to content
Sign inOpen the app
Artwork for BioBoss
BioBoss · February 28 · 31 min

David Southwell: CEO of Volastra Therapeutics

David Southwell, CEO of Volastra Therapeutics, shares his insights about leadership in biopharma and how Volastra is working to discover and develop oncology therapeutics targeting chromosomal instability, a vulnerability of cancers.

0:00-31:26
Play in podnod
Transcript file

transcript

No transcript — this publisher did not publish one.

show notes

David Southwell, CEO of Volastra Therapeutics, shares his insights about leadership in biopharma and how Volastra is working to discover and develop oncology therapeutics targeting chromosomal instability, a vulnerability of cancers.

more episodes

All episodes